[WHO classification of head and neck tumours 2017: Main novelties and update of diagnostic methods].

Abstract:

:The publication of the new WHO classification of head and neck tumours in 2017 brought major modifications. Especially, a new chapter is dedicated to the oropharynx, focusing on the description of squamous cell carcinoma induced by the virus Human Papilloma Virus (HPV), and new entities of tumors are described in nasal cavities and sinuses. In this article are presented the novelties and main changes of this new classification, as well as the updates of the diagnostic methods (immunohistochemistry, cytogenetics or molecular biology).

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Sarradin V,Siegfried A,Uro-Coste E,Delord JP

doi

10.1016/j.bulcan.2018.04.004

subject

Has Abstract

pub_date

2018-06-01 00:00:00

pages

596-602

issue

6

eissn

0007-4551

issn

1769-6917

pii

S0007-4551(18)30132-2

journal_volume

105

pub_type

杂志文章,评审
  • [Conservative management of malignant and borderline ovarian tumor].

    abstract::Conservative management of at least a part of one ovary and the uterus, in order to preserve fertility-potential, could be propose in most of patients with nonepithelial and borderline ovarian tumor. This conservative management could be performed even in patients with borderline ovarian tumor associated with noninvas...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Morice P,Camatte S,Wickart-Poque F,Rouzier R,Pautier P,Pomel C,Lhommé C,Haie-Meder C,Duvillard P,Castaigne D

    更新日期:2002-12-01 00:00:00

  • [Allorecognition of the recipient after hematopoietic transplantation].

    abstract::Donor allorecognition of the recipient after hematopoietic transplantation can result in graft-versus-host disease, a potent graft-vs-leukemia effect as well as a graft facilitation effect. Danger signals, host Ag-presenting cells and minor histocompatibility Ag have recently emerged as major determinants of such an a...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Tiberghien P,Robinet E,Ferrand C,Saas P,Hervé P

    更新日期:2003-08-01 00:00:00

  • [Cervical cancer screening for high risk women: is it possible? Results of a cervical cancer screening program in three suburban districts of Lyon].

    abstract::Between november 1993 and october 1996, a cervical screening program was proposed for women 25-65-year-old who tend to have little or no medical supervision, in three suburban districts of Lyon. The data and results of the two last Pap-smears have been collected together with details of gynecological follow-up. Both g...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Mignotte H,Perol D,Fontanière B,Nachury LP,Blanc-Jouvand A,Fouillat V,Chauvin F,Lasset C

    更新日期:1999-06-01 00:00:00

  • [10-year retrospective analysis of the sequelae of loco-regional treatment of breast cancer].

    abstract::With a minimum follow-up period of 10 years, the incidence of sequelae after loco-regional treatment of 349 breast cancers remains low, being dominated by lymphoedema. Rare after treatment by irradiation alone, lymphoedema appears more frequently in patients treated by radio-surgical association, in spite of a moderat...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Calitchi E,Cheula JM,Otmezguine Y,Roucayrol AM,Mazeron JJ,Le Bourgeois JP,Pierquin B

    更新日期:1984-01-01 00:00:00

  • Traitement focal et traitement systémique dans la prise en charge du cancer du rein métastatique : une question de complémentarité.

    abstract:FOCAL TREATMENT AND SYSTEMIC THERAPY IN METASTATIC KIDNEY CANCER:COMPLEMENTARY APPROACHES: To treat metastatic renal cell carcinoma, therapies used are with an oral intake, for the vast majority, and have many side effects that may compromise observance. Strategies of drug holiday have been studied and, in case of an i...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/S0007-4551(18)30376-X

    authors: Salabert L,Sionneau B,Cochin V,Ravaud A,Gross-Goupil M

    更新日期:2018-12-01 00:00:00

  • [Metastasis to unusual sites].

    abstract::Metastases are responsible for the majority of deaths from solid cancers. Metastatic phenomenon, complex, is a multi-step process where interactions between cells and with the microenvironment are essential. The organ tropism, that is the propensity of a cancer to metastasize to specific organs, can be explained by se...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2014.1889

    authors: Olivier T,Gastaud L,Maschi C,Caujolle JP,Cupissol D,Thariat J

    更新日期:2014-02-01 00:00:00

  • [Interest of studying the in vitro genotoxicity of an antineoplastic drug on healthy human cells: paclitaxel example].

    abstract::Paclitaxel is often used as an adjuvant antineoplastic agent. However, very little data is available in literature on its potential genotoxicity on healthy human cells. Our objective is to study the potential in vitro genotoxicity of paclitaxel, by using the cytokinesis-blocked micronucleus assay in combination with f...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Digue L,Orsière T,Baciuchka-Palmaro M,Duffaud F,Pompili J,Favre R,Botta A

    更新日期:2002-10-01 00:00:00

  • Open-label randomized multi-center phase 2 study: gemcitabine cisplatin plus avelumab or gemcitabine cisplatin as first-line treatment of patients with locally advanced or metastatic urothelial bladder carcinoma: GCisAve.

    abstract:BACKGROUND:The standard treatment in first line of advanced or metastatic urothelial bladder cancer (MBC) is the association of Gemcitabine and Cisplatin (GC). Avelumab, an anti-PD-L1 agent, has recently demonstrated efficacy. The objective is to evaluate the combination of these 3 agents. METHODS:This phase II random...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/S0007-4551(20)30280-0

    authors: Gross-Goupil M,Domblides C,Lefort F,Ravaud A

    更新日期:2020-06-01 00:00:00

  • [Treatment of mucositis pain: News and prospects].

    abstract::Mucositis, an acute inflammation of the digestive mucosa, is one of the main toxicities secondary to oncological treatments. Among its consequences, mucositis-related pain is an important complication due to its intensity and repercussion, especially on quality of life. Treatment of pain plays a central role in manage...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2019.03.022

    authors: Guerrini-Rousseau L,Marec-Berard P,Bolle S,Laurent S

    更新日期:2019-09-01 00:00:00

  • [Angiogenesis and hematologic malignancy].

    abstract::Angiogenesis plays an important role in the progression of tumors. This relationship has been described in several hematologic malignancies. Vascular endothelial growth factor and basic fibroblast growth factor are predictors of poor prognosis in leukemia and non Hodgkin's lymphoma. Bone marrow microvessels were found...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Zini JM,Tobelem G

    更新日期:2007-07-01 00:00:00

  • [Combination of chemotherapy (vindesine, lomustine, cisplatin, cyclophosphamide) and thoracic radiotherapy in nonresectable non-small cell bronchial carcinoma: final results of a phase II clinical trial].

    abstract::Seventy-five patients with locally advanced non small cell lung carcinoma were entered in a phase II study combining chemotherapy (vindesine, lomustine, cisplatin and cyclophosphamide) and radical thoracic radiotherapy delivering a total dose of 60-65 Gy. Patients were regularly assessed by radiological and fiberoptic...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章

    doi:

    authors: Nasr E,Pellae-Cosset B,Arriagada R,Le Chevalier T,Baldeyrou P,Ruffie P,de Cremoux H,Martin M,Tarayre M

    更新日期:1992-01-01 00:00:00

  • [Update on docetaxel and breast cancer].

    abstract::Docetaxel (Taxotère) has been developed in breast cancer during the last decade. First its activity in monotherapy was proven in metastatic setting after failure of anthracycline therapy. Then the association with anthracycline demonstrated substantial activity leading to its development in early stages of breast canc...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Diéras V,Girre V,Pierga JY,Laurence V,Piperno-Neumann S,Pouillart P

    更新日期:2004-05-01 00:00:00

  • [Anticancerous chemotherapy and the general practitioner].

    abstract::The evolution of anti-cancer chemotherapy has led to long duration treatments, which preferentially are given at home, with the participation of the general practitionner (G.P.). The indications and general supervision of these belong to the oncologist, so thus necessitates a coordinated effort between the many physic...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Hoerni B,Chauvergne J,Durand M,Lagarde C

    更新日期:1976-01-01 00:00:00

  • Primary signet ring cell carcinoma of the colon and rectum.

    abstract::Colorectal primary signet ring cell carcinoma (SRCC) is a rare entity accounting for nearly 1% of all colorectal carcinomas. It is an independent prognostic factor associated with less favorable outcome. This aggressiveness is mainly due to the intrinsic biology of these tumors. Here is an overview of the literature r...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2015.07.005

    authors: Arifi S,Elmesbahi O,Amarti Riffi A

    更新日期:2015-10-01 00:00:00

  • [Radiotherapy of bone metastases].

    abstract::Sixty percent of cancer patients have or develop bone metastases during the development of their cancer. Bone metastases are the most common cause of cancer-related pain. External radiation therapy is the standard treatment of uncomplicated bone metastases, for the treatment of pain, the prevention of fracture, and fo...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2013.1845

    authors: Leysalle A,Fric D,Lagrange JL,Thariat J

    更新日期:2013-11-01 00:00:00

  • [P53 genes and solid tumors].

    abstract::The p53 gene is known to play a central role in cancer. In fact, no human tumor type is devoid of p53 mutations, although differences can be seen in the relative frequencies and patterns of nucleotide substitutions. Our work illustrates these differences, since frequencies of mutations ranged from 15 to 80% and the pa...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Theillet C

    更新日期:1993-08-01 00:00:00

  • Pain burden in desmoid tumor patients: a survey of the French Advocacy Group SOS Desmoid.

    abstract:INTRODUCTION:The French Patient Advocacy Group SOS Desmoid conducted a survey to measure the pain burden of desmoid tumor patients. MATERIAL AND METHODS:We used a structured questionnaire to measure the occurrence and consequences of pain. RESULTS:The pain occurrence was approximately 63%. In one-third of the cases, ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2015.02.001

    authors: Rigaux P,Lefebvre-Kuntz D,Penel N,“SOS Desmoïde”.

    更新日期:2015-03-01 00:00:00

  • [TRP calcium channel and breast cancer: expression, role and correlation with clinical parameters].

    abstract::Breast cancer (BC) has the highest incidence rate in women in industrialized countries. Statistically, it is estimated that one out of 10 women will develop BC during her life. Evidence is accumulating for the role of ion channels in the development of cancer. Most studied ion channels in BC are K(+) channels, which a...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2012.1595

    authors: Ouadid-Ahidouch H,Dhennin-Duthille I,Gautier M,Sevestre H,Ahidouch A

    更新日期:2012-06-01 00:00:00

  • [Registry of cancers of the upper respiratory and digestive tract at the Northern and Pas-de-Calais departments from 1984 to 1986].

    abstract::Northern France is known to have the highest mortality rate for cancers of the upper aerodigestive tract (UADT); a UADT cancer registry was therefore set up in this region in January 1984. Three years of meticulous registration provided some significant information. The incidence of UADT cancer was alarming: 4538 UADT...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Adenis L,Lefebvre JL,Cambier L

    更新日期:1988-01-01 00:00:00

  • [Pulmonary malt lymphoma].

    abstract::This review will describe the current knowledge in the pathophysiology, diagnosis, prognosis and treatment of pulmonary MALT (Mucosa Associated Lymphoid Tissue) lymphoma. Pulmonary MALT lymphomas are low-grade B cell lymphoma and are the most frequent lymphomas arising from the lung. Tumour cells arise from mucosa ass...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2014.1885

    authors: Borie R,Antoine M,Cadranel J,Wislez M

    更新日期:2014-02-01 00:00:00

  • [Assessment of HER2 status in breast cancer].

    abstract::HER2-positive status is the sole criterion for identifying patients with breast cancer for Herceptin (trastuzumab) therapy. Accurate assessment of HER2 status is essential to ensure that all patients who may benefit from Herceptin are correctly identified. There are several assays available to determine HER2 status: t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Penault-Llorca F,Cayre A

    更新日期:2004-12-01 00:00:00

  • [Merkel cell carcinoma: diagnostic and treatment].

    abstract::Merkel cell carcinoma (MCC) is an uncommon neuro-endocrine tumor of the sun-exposed skin predominantly observed in white patients in the sixth decade of the life. In electron microscopy MCC characteristically contains dense core secretory granules. This tumor expresses both epithelial (keratins of low molecular weight...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Voog E,Blay JY

    更新日期:1999-07-01 00:00:00

  • [Doxifluridine toxicity, a fluorouracil analog with low myelosuppressive effect].

    abstract::Doxifluridine, a new fluorouracil analog with a low myelosuppressive effect, has recently been subject to various disease-oriented, Phase II trials. For the present evaluation of drug tolerance, the Phase II data of 114 patients having received 376 doxifluridine cycles has been used. The treatment cycles consisted of ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Winkelmann JJ,Alberto P,Mermillod B

    更新日期:1990-01-01 00:00:00

  • [Urothelial tumors in children].

    abstract::Urothelial tumors are very rare in children (to date, only about 150 cases have been reported worlwide). Only 20% occur before the age of ten. The aim of this study is to specify the clinicopathologic features of urothelial tumor in young patients, which require a slightly different approach to treatment. On the basis...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2016.11.018

    authors: Grapin-Dagorno C,Peycelon M,Philippe-Chomette P,Berrebi D,El Ghoneimi A,Orbach D

    更新日期:2017-02-01 00:00:00

  • [Molecular mechanisms of oncogenic transformation: what's new?].

    abstract::During the past two years, new molecular targets have been discovered which link cell cycle, cell proliferation and cellular growth. It has become more and more evident that whereas gain-of-function mutations in specific genes can lead to cancer, genomic instability plays also an important role in tumour progression. ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Blanchard JM

    更新日期:2002-01-01 00:00:00

  • [Carcinoembryonic antigen in carcinoma of the uterine cervix (author's transl)].

    abstract::The authors analyse 123 cases of carcinoma of the uterine cervix treated by radiotherapy, with CEA radio-immuno-assay performed before treatment then each time patients are seen in follow-up. The CEA level is positive in 35 per cent of the cases with a mean value of 21 per cent for stage I, 36 per cent for stage II an...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Bolla M,Vrousos C,Horiot JC,Bordes M,Le Dorze C

    更新日期:1979-01-01 00:00:00

  • [Li-Fraumeni syndrome].

    abstract::The Li-Fraumeni syndrome is an autosomal dominant syndrome representing a genetic predisposition to a wide spectrum of tumours including sarcomas, breast carcinomas, brain tumors and adrenocortical carcinomas. In most of the cases, tumours will develop in children and young adults. Germline mutations of the tumor supp...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Frebourg T

    更新日期:1997-07-01 00:00:00

  • [Chemoradiotherapy and anal canal cancer].

    abstract::Local control and sphincter preservation are the two challenges of anal canal cancer treatment. These tumors are radio- and chemo-sensitive and treatment moved from surgical approach, with abdominoperineal resection, to definitive radiation therapy with or without concurrent chemotherapy. Randomised trials proved the ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Ortholan C,François E,Gérard JP

    更新日期:2005-12-01 00:00:00

  • [Chemotherapy combining vindesine, thiotepa and methotrexate in metastatic breast cancer after failure of a combination containing anthracycline. Results of a prospective phase II trial].

    abstract::Twenty-six patients with metastatic breast cancer where treated, after failure of a first line chemotherapy including an anthracycline, with a second line combination of vindesine, methotrexate and thiotepa. Overall tolerance of this treatment was good. There were one complete response and two partial responses. The a...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Comoz M,Chevallier B,Bastit P

    更新日期:1988-01-01 00:00:00

  • [What do we know about ATM protein expression in breast tissue?].

    abstract::The great majority of breast cancer cases are not associated with a mutated gene of high penetrance such as BRCA1, BRCA2 and TP53. Genes of low penetrance, frequently mutated in the general population, might play an important role in breast cancer development. The ATM gene, which encodes the ATM protein, mutated in th...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Angèle S,Tanière P,Hall J

    更新日期:2001-07-01 00:00:00